EB Medicine

JANUARY 17, 2023

Announcements: The interactive Clinical Pathways have launched and they are available for free! — In this episode, Sam Ashoo, MD, and TR Eckler, MD, discuss the July 2022 Emergency Medicine Practice article on the Management of Allergic Reactions and Anaphylaxis in the Emergency Department. Intro The number of ED visits and hospitalizations (..)

Allergic Reactions 52

Allergic Reactions Anaphylaxis Infectious Diseases Emergency Department 52

EMDocs

AUGUST 31, 2023

Accessed May 7, 2022. Accessed May 7, 2022. Accessed May 7, 2022. Accessed May 7, 2022. StatPearls Publishing; 2022. Accessed May 17, 2022. Table 1: Comparison of F(ab) and F(ab’) 2 antivenoms. References: Ubani C, DeGelorm A, Sollee D. Poison Control: The F(ab2)ulous Expanded Indication of Anavip | FCEP.

Allergic Reactions 97

Allergic Reactions Anaphylaxis Poisoning EMS 97

EMDocs

FEBRUARY 7, 2024

American Gastroenterological Association issued a practice guideline in November 2022 recommending that semaglutide 2.4 Retrospective study published in 2022 of 81,752 adverse events associated with GLP-1 agonist therapy found an increased risk of pancreatitis, particularly with liraglutide (ROR 32.67; 95% CI 29.44-36.25).

Allergic Reactions 97

Allergic Reactions Anaphylaxis Dehydration Wellness 97

RebelEM

AUGUST 3, 2023

What They Did: Parallel, 2-arm, noninferiority, open-label, multicenter, international randomized clinical trial Occurred in 6 specialized centers (3 in North America – US & Canada and 3 Outside of North America – Australia) Trial took place from June 2021 to December 2022 Used PEN-FAST to risk stratify patients.

Anaphylaxis 52

Anaphylaxis Allergic Reactions Infectious Diseases Outcomes 52